Again, EGFR/ErbB2 heterodimers increase the metastatic potential of BC cell lines [198] and the BC basal type, often classified as TNBC, is characterized by EGFR overexpression that results in chemo- and radio-resistance to chemotherapy and radiation treatment, hence leading to poor prognosis and survival [199,200]. Here, ERBB2 is linked to breast cancer.